New Combination Chemotherapy Drug for Mesothelioma
A recent study has found that a new drug for mesothelioma chemotherapy could improve treatment outcomes. The new drug is…
Immune Checkpoint Therapy for Mesothelioma
A new study suggests that immune checkpoint therapy with nivolumab is a promising treatment for a specific type of mesothelioma.…
Genetics | New Drugs | Research | Treatments
New Self-Administered Inhaled Gene Therapy Linked to Mesothelioma Survival
A team of doctors in Japan have developed a new oral inhaled gene therapy for the treatment of mesothelioma. This…
The First FDA-Approved Mesothelioma Drug in 15 Years
On October 2, 2020, the first FDA-approved mesothelioma drug in 15 years hit the market. They approved a new combination…
New Drug Targeting Fibrosis may Help Mesothelioma Patients
Targeting fibrosis has therapeutic benefits in mesothelioma. Most drugs have limited effects in difficult-to-treat cancers such as mesothelioma. Often this…
New Treatment for Malignant Mesothelioma Kills Cancer ‘From the Inside Out’
The University of Vermont is about to start a first-in-human trial of a new kind of treatment for malignant mesothelioma. …
Targeting Nerve Cells Might Offer New Way to Fight Mesothelioma, Other Cancers
Israeli scientists may have found a new way to fight mesothelioma and other cancers from the inside out by targeting…
Quinacrine for Mesothelioma? Anti-Malaria Drug May Help Patients with This Gene Mutation
Another study on quinacrine for mesothelioma suggests that the once-popular anti-malaria drug might help a subset of patients with a…
Alternatives | New Drugs | New Studies | Research | Surgery | Treatments
Cancer-Fighting Gel Could “Change the Treatment Paradigm” for Mesothelioma
New National Cancer Institute research shows a cancer-fighting gel applied directly to the surface of a mesothelioma tumor could “change…
Europe | International | New Drugs | New Studies | Research | Treatments
Second-Line Treatment with Ramucirumab Improves Mesothelioma Survival
New evidence suggests that second-line treatment with ramucirumab after first-line chemotherapy may lead to longer survival in people with pleural…